ZYDUS HEPTIZA
Cadila Healthcare jumps 5% as drugmaker inks pact for Hepatitis C tabletsThe agreement sub-licenses Zydus to produce and sell daclatasvir in 112 low and middle income countries, it added.
Zydus Cadila launches Gilead's Hepatitis C drug in IndiaSofosbuvir is a medicine used for chronic hepatitis C infection and sold globally by Gilead Sciences Inc, under its brand Sovaldi.
- Load More